Home / Inspections / 1012412

FDA Inspection 1012412 — Akorn, Inc.

Akorn, Inc. — FEI 3003102962

The FDA completed an inspection of Akorn, Inc. on March 20, 2017 in Gurnee, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 20, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Gurnee, IL (United States)

Facility

Other inspections at this facility

  • 1085157 (NAI Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1004511 (NAI Mon Feb 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 950673 (NAI Fri Dec 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 629551 (VAI Tue Nov 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources